How do you treat patients with MDS and anemia?

A roundtable discussion on anemia management in myelodysplastic syndromes (MDS), featuring moderator Guillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center; Amy DeZern, MD, MHS, of Johns Hopkins Medicine; Tiffany Tanaka, MD, of the University of California San Diego; and Uma Borate, MBBS, of Ohio State University, focused on tailoring treatment to patient needs. The assessing anemia based on symptoms such as fatigue, alongside hemoglobin levels, to guide therapy. The panel also discussed strategic sequencing and treating with luspatercept in ring sideroblast-positive patients.

Watch more of the MDS roundtable discussion.